Private Market View

PrimeGene (Beijing)

Beijing, China · Founded 2016 · Privately Held (backing)

Last price · $/share
Implied valuation
$248.0M
Total raised
$85.6M
Last round
What is PrimeGene (Beijing) worth?
$248.0Mlast known valuation
Free account
See the evidence behind this price
  • ·The complete investor list — 8 names
  • ·Watchlist + deal alerts for PrimeGene (Beijing)
  • ·The full record, as it builds
Create free account
No card required

Funding history

No rounds on record

No funding rounds for PrimeGene (Beijing) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How PrimeGene (Beijing)'s valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For PrimeGene (Beijing), too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is PrimeGene (Beijing) worth?
PrimeGene (Beijing)'s last known valuation is $248.0M.
How much has PrimeGene (Beijing) raised?
PrimeGene (Beijing) has raised $85.6M in total funding across its recorded rounds.